Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- 28 February 2011
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (2), 246-251
- https://doi.org/10.1016/j.bbadis.2010.05.012
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiationThe Journal of Experimental Medicine, 2009
- Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2009
- T-bet is essential for encephalitogenicity of both Th1 and Th17 cellsThe Journal of Experimental Medicine, 2009
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionThe Journal of Experimental Medicine, 2008
- Differential regulation of central nervous system autoimmunity by TH1 and TH17 cellsNature Medicine, 2008
- Phenotypic and functional features of human Th17 cellsThe Journal of Experimental Medicine, 2007
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- T‐bet is essential for the progression of experimental autoimmune encephalomyelitisImmunology, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003